|Articles|November 1, 2013
- BioPharm International-11-01-2013
- Volume 26
- Issue 11
BioPharm International, November 2013 Issue (PDF)
Click the title above to open the BioPharm International November 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 12 years ago
Metacomplex Formation and Binding Affinity of Multivalent Binding Partnersalmost 12 years ago
Supplier-Change Management for Drug-Product Manufacturersalmost 12 years ago
Report from Brazilalmost 12 years ago
Risk Aversion and Closed-System Processingalmost 12 years ago
The State of the Used-Equipment Marketalmost 12 years ago
Challenges in Managing the Cold Chainalmost 12 years ago
European Union Introduces GMPs for Excipientsalmost 12 years ago
Congress Revises Rules for Drug Compounding and Supply-Chain Securityalmost 12 years ago
USP Plans Standards on Good Distribution Practicesalmost 12 years ago
New Funding and Approval Pathways Prove PopularNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Novartis–Avidity Biosciences Deal Highlights Next-Gen RNA Manufacturing Potential
2
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
3
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
4
Welcome to CPHI Frankfurt 2025
5
